Vaxdyn: Funding, Investors & Team (Sep 2026)
Vaxdyn is a developer of multi-valent vaccines for preventing antibiotics-resistant infections.
Vaxdyn has raised $12.8M across 1 funding round on record, the most recent a Series A of $12.8M announced in Sep 2026.
That round is above the $3.1M median round size for Spain companies tracked on FundedIQ over the last two years.
Vaxdyn Company Profile and Key Stats
Latest funding round on record: Sep 2026.
Vaxdyn Funding Rounds
Vaxdyn Investors
9 investors are recorded in total; the 5 named above are those the record identifies.
Vaxdyn Founders and Leadership Team
Contact details for the Vaxdyn team: 1 has a LinkedIn profile.
Start 14-day free trial →Vaxdyn Funding in Context
Vaxdyn's latest round of $12.8M is above the median round in Spain. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Vaxdyn in Biotechnology and Sevilla
Companies Similar to Vaxdyn
Heydiga is an AI-powered conversation layer for small businesses.
Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of…
Deneb Medical provides solutions to overcome the human limitations in surgery for spine surgeons.
MOA creates nutritious food for a sustainable world to meet increasing global food needs by developing a new…
iPronics creates new ideas for versatile integrated programmable photonic systems.
iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…
PLD Space is a spanish innovative start-up company is to provide low cost and high reliability access to…
Homvers makes automated, space-saving smart furniture like ceiling-retracting beds.
HelmX develops AI-powered smart helmets that turn everyday industrial fieldwork into continuously updated…
FuVeX specializes in creating, producing, and selling drones. The team at FuVeX aims to enhance the…
Tripjoin gathers people with the intention to travel but has no one to join with.
Smart Management Software for Profesional Communities
Vaxdyn Funding FAQs
What does Vaxdyn do?
Vaxdyn is a developer of multi-valent vaccines for preventing antibiotics-resistant infections.
How much funding has Vaxdyn raised?
Vaxdyn has raised $12.8M across 1 round on record. The most recent is a Series A of $12.8M announced in Sep 2026.
When did Vaxdyn last raise funding?
Vaxdyn's most recent funding round on record is a Series A of $12.8M, announced in Sep 2026.
Who has invested in Vaxdyn?
Investors on record for Vaxdyn include European Innovation Council Fund, CARB-X, Reig Jofre, Biovance Capital, Arquimea Ingeniera. FundedIQ records 9 investors in total.
Who is the CEO of Vaxdyn?
Juan Jose Infante is listed as CEO at Vaxdyn.
Where is Vaxdyn headquartered?
Vaxdyn is based in Sevilla, Spain.
How many employees does Vaxdyn have?
Vaxdyn is in the 11-50 employee band.
When was Vaxdyn founded?
Vaxdyn was founded in 2011.
About FundedIQ's Vaxdyn Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Vaxdyn is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.